Showing results (1-10 of 70) with videos related to
Sort By:
Pageof 7
Pharmacological Research|June 16, 2022
Strengthening regulations, recent advances and remaining barriers in stem cell clinical translation in China: 2015-2021 in reviewChenghai LiFrontiers in Cell and Developmental Biology|June 20, 2022
Mesenchymal Stem/Stromal Cells in Progressive Fibrogenic Involvement and Anti-Fibrosis Therapeutic PropertiesChenghai Li, Bin WangInternational Journal of Biological Macromolecules|July 30, 2016
Purification, characterization and in vitro antioxidant activities of polysaccharide from Chaenomeles speciosaXianfei Xie, Guolin Zou, Chenghai LiDrug Design, Development and Therapy|October 16, 2020
Challenges for Mesenchymal Stem Cell-Based Therapy for COVID-19Chenghai Li, Hua Zhao, Bin WangPlos One|March 18, 2014
Periodic heat shock accelerated the chondrogenic differentiation of human mesenchymal stem cells in pellet cultureJing Chen, Chenghai Li, Sihong WangTranslational Oncology|November 15, 2020
Mesenchymal stem/stromal cells: Developmental origin, tumorigenesis and translational cancer therapeuticsChenghai Li, Hua Zhao, Bin WangCarbohydrate Polymers|August 11, 2015
Antitumor and immunomodulatory activities of a water-soluble polysaccharide from Chaenomeles speciosaXianfei Xie, Guolin Zou, Chenghai LiCell & Bioscience|November 3, 2021
Allogeneic vs. autologous mesenchymal stem/stromal cells in their medication practiceChenghai Li, Hua Zhao, Linna Cheng, et al.Clinics (Sao Paulo, Brazil)|August 9, 2025
Potential function exploration of lncRNAs in idiopathic pulmonary fibrosis: insights from whole transcriptome sequencing data analysisXinran Ma, Dong Chen, Chenghai Li, et al.Drug Design, Development and Therapy|April 7, 2021
Anti-Inflammation, Immunomodulation and Therapeutic Repair in Current Clinical Trials for the Management of COVID-19Chenghai Li, Hua Zhao, Linna Cheng, et al.Pageof 7